Nanomedicine in the management of Alzheimer's disease: State-of-the-art

SN Mir Najib Ullah, O Afzal, ASA Altamimi, H Ather… - Biomedicines, 2023 - mdpi.com
Alzheimer's disease (AD) is a deadly, progressive, and irreversible brain condition that
impairs cognitive abilities. Globally, it affects 32.6 million individuals, and if no viable …

Classics in chemical neuroscience: Donepezil

JT Brewster, S Dell'Acqua, DQ Thach… - ACS Chemical …, 2018 - ACS Publications
The discovery of acetylcholine and acetylcholinesterase provided the first insight into the
intricacies of chemical signal transduction and neuronal communication. Further elucidation …

Discovery of a potent dual inhibitor of acetylcholinesterase and butyrylcholinesterase with antioxidant activity that alleviates Alzheimer-like pathology in old APP/PS1 …

E Viayna, N Coquelle… - Journal of Medicinal …, 2020 - ACS Publications
The combination of the scaffolds of the cholinesterase inhibitor huprine Y and the
antioxidant capsaicin results in compounds with nanomolar potencies toward human …

Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box–Behnken design, in vitro and in vivo evaluation

M Yasir, UVS Sara, I Chauhan, PK Gaur… - Artificial cells …, 2018 - Taylor & Francis
This study was aimed at preparing and characterizing solid lipid nanoparticles (SLNs) of
donepezil (DPL) for delivery to brain via nasal route. SLNs were prepared by solvent …

Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation

J Choi, MK Choi, S Chong, SJ Chung, CK Shim… - International journal of …, 2012 - Elsevier
The effect of fatty acids on the skin permeation of donepezil base (DPB) and its
hydrochloride salt (DPH) were studied in vitro using hairless mouse and human cadaver …

[图书][B] Handbook of forensic toxicology for medical examiners

DK Molina, V Hargrove - 2018 - taylorfrancis.com
Forensic professionals, particularly medical examiners—often working through heavy
caseloads—require quick and easy access to reliable sources of information to help …

Effect of CYP2D6* 10 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer's disease

Y Zhong, X Zheng, Y Miao, H Yan, B Wang… - The American journal of …, 2013 - Elsevier
Background The aim of this study was to evaluate the effect of CYP2D6* 10 and APOE
polymorphisms on both steady-state plasma concentrations (Cp) and clinical response of …

Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC–MS to UPLC–MS/MS

M Noetzli, N Ansermot, M Dobrinas, CB Eap - Journal of pharmaceutical …, 2012 - Elsevier
A previously developed high performance liquid chromatography mass spectrometry (HPLC–
MS) procedure for the simultaneous determination of antidementia drugs, including …

Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer's disease and vascular …

T Yaowaluk, V Senanarong, C Limwongse… - Pharmacogenomics …, 2019 - Taylor & Francis
Purpose This study aims to evaluate the influence of genetic polymorphisms of CYP2D6,
CYP3A5, ABCB1, and APOE genes and nongenetic factors on steady-state plasma …

Evidence of carrier‐mediated transport in the penetration of donepezil into the rat brain

MH Kim, HJ Maeng, KH Yu, KR Lee, T Tsuruo… - Journal of …, 2010 - Elsevier
The objective of this study was to characterize the mechanism that controls the transport of
donepezil into the brain. The apparent brain uptake clearance (CL app, br) was decreased …